Serum biochemistry analysis showed a 71% increase in plasma triglycerides and in circulating levels of TNF-α (84%), IL-1β, IL-6, and leptin (7.7-, 1.4-, and 2-fold) in the MS group when compared to the control group (Table 2). Here, TNF is linked to myeloid sarcoma.